NCT02530931View on ClinicalTrials.gov

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease

PHASE4TerminatedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions

Meniere's Disease

Interventions

DRUG

Gadolinium

diffusion of gadolinium for a population with Meniere's disease in order to develop an imaging disease screening test

Trial Locations (1)

38043

GrenobleUniversityHospital, Grenoble

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Guerbet

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT02530931 - Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease | Biotech Hunter | Biotech Hunter